APA (7th ed.) Citation

EL, S., CS, B., GL, M., & DM, W. (2022). Can ParC Ser83Ile status predict fluoroquinolone efficacy in Mycoplasma genitalium infection? - Authors' reply. The Lancet. Infectious diseases, 22(9), 1274. https://doi.org/10.1016/S1473-3099(22)00446-7

Chicago Style (17th ed.) Citation

EL, Sweeney, Bradshaw CS, Murray GL, and Whiley DM. "Can ParC Ser83Ile Status Predict Fluoroquinolone Efficacy in Mycoplasma Genitalium Infection? - Authors' Reply." The Lancet. Infectious Diseases 22, no. 9 (2022): 1274. https://doi.org/10.1016/S1473-3099(22)00446-7.

MLA (9th ed.) Citation

EL, Sweeney, et al. "Can ParC Ser83Ile Status Predict Fluoroquinolone Efficacy in Mycoplasma Genitalium Infection? - Authors' Reply." The Lancet. Infectious Diseases, vol. 22, no. 9, 2022, p. 1274, https://doi.org/10.1016/S1473-3099(22)00446-7.